Control of steroid-associated osteonecrosis of the femoral head in SLE patients
Clinical trial for the control of osteonecrosis of the femoral head secondary to the initial corticosteroid treatment in patients with systemic lupus erythematosus - None Clinical trial for the control of osteonecrosis of the femoral head secondary to the initial cortico ...
systemic lupus erythematosus;D008180
Objectives take three below candidate drugs for the prevention for at least 3 months after the initial corticosteroid treatment. 1. Clopidogrel Bisulfate (Plavix) Taking a dose of 300mg once daily on the first day, and a dose of 75mg once daily on subsequent days. 2. PitavastatinCalcium (LIVALO) Taking a dose of 2mg once daily. 3. Tocopherol Acetate (Juvela) Taking a dose of 100mg three times daily (total of 300mg daily). Objectives take three below candidate drugs for the prevention for at least 3 months after the initi ...
Clinical trial for the control of osteonecrosis of the femoral head secondary to the initial corticosteroid treatment in patients with systemic lupus erythematosus Clinical trial for the control of osteonecrosis of the femoral head secondary to the initial cortico ...
Clinical trial for the control of osteonecrosis of the femoral head secondary to the initial corticosteroid treatment in patients with systemic lupus erythematosus - Control of steroid-induced osteonecrosis of the femoral head in SLE patients Clinical trial for the control of osteonecrosis of the femoral head secondary to the initial cortico ...
Systemic lupus erythematosus
Objectives take three below candidate drugs for the prevention for at least 3 months after the initial corticosteroid treatment. 1. Clopidgrel Bisulfate (Plavix) Taking a dose of 300mg once daily on the first day, and a dose of 75mg once daily on subsequent days. 2. PitavastatinCalcium (LIVALO) Taking a dose of 2mg once daily. 3. Tocopherol Acetate (Juvela) Taking a dose of 100mg three times daily (total of 300mg daily). Objectives take three below candidate drugs for the prevention for at least 3 months after the initi ...
Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University